These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30854738)

  • 41. Site-Specific Chemical Conjugation of Antibodies by Using Affinity Peptide for the Development of Therapeutic Antibody Format.
    Kishimoto S; Nakashimada Y; Yokota R; Hatanaka T; Adachi M; Ito Y
    Bioconjug Chem; 2019 Mar; 30(3):698-702. PubMed ID: 30606013
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Advances in the Development of Site-Specific Antibody-Drug Conjugation.
    Zhou Q; Kim J
    Anticancer Agents Med Chem; 2015; 15(7):828-36. PubMed ID: 25731178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sortase Enzyme-Mediated Generation of Site-Specifically Conjugated Antibody Drug Conjugates with High In Vitro and In Vivo Potency.
    Beerli RR; Hell T; Merkel AS; Grawunder U
    PLoS One; 2015; 10(7):e0131177. PubMed ID: 26132162
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Application of Native Ion Exchange Mass Spectrometry to Intact and Subunit Analysis of Site-Specific Antibody-Drug Conjugates Produced by AJICAP First Generation Technology.
    Matsuda Y; Kliman M; Mendelsohn BA
    J Am Soc Mass Spectrom; 2020 Jul; ():. PubMed ID: 32608232
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bioconjugation through Mesitylene Thiol Alkylation.
    Ramos-Tomillero I; Perez-Chacon G; Somovilla-Crespo B; Sanchez-Madrid F; Domínguez JM; Cuevas C; Zapata JM; Rodríguez H; Albericio F
    Bioconjug Chem; 2018 Apr; 29(4):1199-1208. PubMed ID: 29433317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Site-specific antibody-drug conjugation through an engineered glycotransferase and a chemically reactive sugar.
    Zhu Z; Ramakrishnan B; Li J; Wang Y; Feng Y; Prabakaran P; Colantonio S; Dyba MA; Qasba PK; Dimitrov DS
    MAbs; 2014; 6(5):1190-200. PubMed ID: 25517304
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elimination of melanoma by sortase A-generated TCR-like antibody-drug conjugates (TL-ADCs) targeting intracellular melanoma antigen MART-1.
    Lai J; Wang Y; Wu SS; Ding D; Sun ZY; Zhang Y; Zhou J; Zhou Z; Xu YC; Pan LQ; Chen SQ
    Biomaterials; 2018 Sep; 178():158-169. PubMed ID: 29933102
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficient Preparation of Site-Specific Antibody-Drug Conjugates Using Phosphopantetheinyl Transferases.
    Grünewald J; Klock HE; Cellitti SE; Bursulaya B; McMullan D; Jones DH; Chiu HP; Wang X; Patterson P; Zhou H; Vance J; Nigoghossian E; Tong H; Daniel D; Mallet W; Ou W; Uno T; Brock A; Lesley SA; Geierstanger BH
    Bioconjug Chem; 2015 Dec; 26(12):2554-62. PubMed ID: 26588668
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current strategies in antibody engineering: Fc engineering and pH-dependent antigen binding, bispecific antibodies and antibody drug conjugates.
    Vincent KJ; Zurini M
    Biotechnol J; 2012 Dec; 7(12):1444-50. PubMed ID: 23125076
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preparation of immunoconjugates using antibody oligosaccharide moieties.
    Vogel CW
    Methods Mol Biol; 2004; 283():87-108. PubMed ID: 15197304
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insights from native mass spectrometry approaches for top- and middle- level characterization of site-specific antibody-drug conjugates.
    Botzanowski T; Erb S; Hernandez-Alba O; Ehkirch A; Colas O; Wagner-Rousset E; Rabuka D; Beck A; Drake PM; Cianférani S
    MAbs; 2017 Jul; 9(5):801-811. PubMed ID: 28406343
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Novel Chemical Linkers for Next-generation Antibody-drug Conjugates(ADCs)].
    Tsuchikama K
    Yakugaku Zasshi; 2019; 139(2):209-219. PubMed ID: 30713230
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel Hybrid Compound of a Plinabulin Prodrug with an IgG Binding Peptide for Generating a Tumor Selective Noncovalent-Type Antibody-Drug Conjugate.
    Muguruma K; Yakushiji F; Kawamata R; Akiyama D; Arima R; Shirasaka T; Kikkawa Y; Taguchi A; Takayama K; Fukuhara T; Watabe T; Ito Y; Hayashi Y
    Bioconjug Chem; 2016 Jul; 27(7):1606-13. PubMed ID: 27304609
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Traceless Site-Specific Conjugation on Native Antibodies Enables Efficient One-Step Payload Assembly.
    Zeng Y; Shi W; Dong Q; Li W; Zhang J; Ren X; Tang C; Liu B; Song Y; Wu Y; Diao X; Zhou H; Huang H; Tang F; Huang W
    Angew Chem Int Ed Engl; 2022 Sep; 61(36):e202204132. PubMed ID: 35737596
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Spontaneous Isopeptide Bond Formation as a Powerful Tool for Engineering Site-Specific Antibody-Drug Conjugates.
    Siegmund V; Piater B; Zakeri B; Eichhorn T; Fischer F; Deutsch C; Becker S; Toleikis L; Hock B; Betz UA; Kolmar H
    Sci Rep; 2016 Dec; 6():39291. PubMed ID: 27982100
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibody-drug conjugates: recent advances in conjugation and linker chemistries.
    Tsuchikama K; An Z
    Protein Cell; 2018 Jan; 9(1):33-46. PubMed ID: 27743348
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recent developments in chemical conjugation strategies targeting native amino acids in proteins and their applications in antibody-drug conjugates.
    Kang MS; Kong TWS; Khoo JYX; Loh TP
    Chem Sci; 2021 Oct; 12(41):13613-13647. PubMed ID: 34760149
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Innovative native MS methodologies for antibody drug conjugate characterization: High resolution native MS and IM-MS for average DAR and DAR distribution assessment.
    Debaene F; Boeuf A; Wagner-Rousset E; Colas O; Ayoub D; Corvaïa N; Van Dorsselaer A; Beck A; Cianférani S
    Anal Chem; 2014 Nov; 86(21):10674-83. PubMed ID: 25270580
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Site-specific antibody-drug conjugates: the nexus of bioorthogonal chemistry, protein engineering, and drug development.
    Agarwal P; Bertozzi CR
    Bioconjug Chem; 2015 Feb; 26(2):176-92. PubMed ID: 25494884
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sensitive ELISA Method for the Measurement of Catabolites of Antibody-Drug Conjugates (ADCs) in Target Cancer Cells.
    Salomon PL; Singh R
    Mol Pharm; 2015 Jun; 12(6):1752-61. PubMed ID: 25738394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.